CSLLY - Pfizer wins Canada approval for hemophilia B gene therapy
2024-01-03 10:19:29 ET
More on Pfizer
- The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations
- Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase
- Pfizer: Buy The Panic
- Drugmakers reportedly planning to raise prices on 500+ drugs in January
- Pfizer in 2024: What to expect?
For further details see:
Pfizer wins Canada approval for hemophilia B gene therapy